|
MechanismCav2.1 inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Sweden |
First Approval Date28 Mar 1998 |
100 Clinical Results associated with Himont, Inc.
0 Patents (Medical) associated with Himont, Inc.
01 Oct 1995·Macromolecular Symposia
High performance polyolefins: The new way towards engineering plastics applications
Author: J. C. Haylock ; A. Denicola ; P. Galli
A review with 4 references on high performance polyolefins, including Ziegler-Natta catalysts and alloys.
01 Jan 1988·Acta Polymerica
New frontiers in polymers blends: The synthesis alloys
Author: Del Duca, D. ; Simonazzi, T. ; Galli, P.
AbstractNew catalyst systems for the synthesis of polypropylene and polypropylene copolymers have been developed. The growth mechanisms of morphological structure of the polymers and some features of the process are described. Some properties of the obtained homopolymers and copolymers are presented, and the advantages and future developments of the process technology are discussed.
01 Dec 1987·American Industrial Hygiene Association journal
Health protection in an international industrial setting.
100 Deals associated with Himont, Inc.
100 Translational Medicine associated with Himont, Inc.